Mitochondrial impairment in p53-deficient human cancer cells

被引:93
作者
Zhou, S [1 ]
Kachhap, S [1 ]
Singh, KK [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Sidney Kimmel Canc Ctr, Baltimore, MD 21231 USA
关键词
D O I
10.1093/mutage/18.3.287
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The mechanism linking p53 inactivation to human cell malignancy remains unclear. Studies have indicated that mitochondrial dysfunction is involved in carcinogenesis. In this study we investigated the role of p53 in mitochondrial DNA (mtDNA) mutation and maintenance of proper mitochondrial function. We measured mtDNA mutation and found no difference in frequency of mutation between the p53(+/+) and p53(-/-) cell lines. However, mitochondrial cytochrome c oxidase (COX) activity was significantly diminished in p53(-/-) cells. This decrease in COX activity was attributed to decreased protein levels of the COXII subunit encoded by the mitochondrial genome and was not due to mutation in the mitochondrial COXII gene. Further investigation revealed no concomitant decrease in COXII mRNA levels in p53(-/-) cells and the stability of mRNA in p53(-/-) cells was unaffected. This study suggests that decreased COX activity is likely due to post-transcriptional regulation of the COXII subunit by p53. COX is a critical enzyme in the mitochondrial electron transport chain and reduced COX activity may affect mitochondrial structure. However, examination of mitochondrial ultrastructure revealed no obvious differences between p53(+/+) and p53(-/-) cell lines. Together, our study suggests that p53 is involved in regulation of COXII at the protein level but not at the mRNA level. p53 does not affect mtDNA mutation or mitochondrial ultrastructure.
引用
收藏
页码:287 / 292
页数:6
相关论文
共 55 条
  • [41] Mitochondrial DNA in human malignancy
    Penta, JS
    Johnson, FM
    Wachsman, JT
    Copeland, WC
    [J]. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2001, 488 (02) : 119 - 133
  • [42] T7 RNA POLYMERASE-DEPENDENT EXPRESSION OF COXII IN YEAST MITOCHONDRIA
    PINKHAM, JL
    DUDLEY, AM
    MASON, TL
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (07) : 4643 - 4652
  • [43] A model for p53-induced apoptosis
    Polyak, K
    Xia, Y
    Zweier, JL
    Kinzler, KW
    Vogelstein, B
    [J]. NATURE, 1997, 389 (6648) : 300 - 305
  • [44] Somatic mutations of the mitochondrial genome in human colorectal tumours
    Polyak, K
    Li, YB
    Zhu, H
    Lengauer, C
    Willson, JKV
    Markowitz, SD
    Trush, MA
    Kinzler, KW
    Vogelstein, B
    [J]. NATURE GENETICS, 1998, 20 (03) : 291 - 293
  • [45] Prives C, 1999, J PATHOL, V187, P112
  • [46] NONVIABILITY OF CELLS WITH OXIDATIVE DEFECTS IN GALACTOSE MEDIUM - A SCREENING-TEST FOR AFFECTED PATIENT FIBROBLASTS
    ROBINSON, BH
    PETROVABENEDICT, R
    BUNCIC, JR
    WALLACE, DC
    [J]. BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY, 1992, 48 (02): : 122 - 126
  • [47] Singer T P, 1974, Methods Biochem Anal, V22, P123, DOI 10.1002/9780470110423.ch3
  • [48] Singh K.K., 1998, Mitochondrial DNA Mutations in Aging, Disease and Cancer
  • [49] Mitochondrial DNA determines the cellular response to cancer therapeutic agents
    Singh, KK
    Russell, J
    Sigala, B
    Zhang, YG
    Williams, J
    Keshav, KF
    [J]. ONCOGENE, 1999, 18 (48) : 6641 - 6646
  • [50] SUN AS, 1980, CANCER RES, V40, P4677